AVROBIO Receives No Objection to Clinical Trial Application from Health Canada for AVR-RD-02 Gene Therapy for Gaucher Disease
E-Power Resources Inc. Announces Closing of Oversubscribed Hard Dollar and Flow-through Private Placements